| HCPCS Code | Code Dosage | Payment Limit |
Vaccine AWP % | Vaccine Limit | Infusion AWP % | DME infusion limit | Blood AWP % | Blood limit | Clotting factor | Note |
|---|---|---|---|---|---|---|---|---|---|---|
Q9963 - High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml |
1 ML | 0.217 | - | - | - | - | - | - | ||
Q9965 - Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
1 ML | 1.555 | - | - | - | - | - | - | ||
Q9966 - Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml |
1 ML | 0.379 | - | - | - | - | - | - | ||
Q9967 - Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
1 ML | 0.141 | - | - | - | - | - | - | ||
Q9991 - Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg |
Less than or equal to 100 MG | 1943.058 | - | - | - | - | - | - | ||
Q9992 - Injection, buprenorphine extended-release (sublocade), greater than 100 mg |
Greater than 100 MG | 1943.058 | - | - | - | - | - | - | ||
| * Effective October 1, 2024 - December 31, 2024 | ||||||||||
Medicare Part B payment allowance limits for drugs not otherwise classified - Effective October 1, 2024 - December 31, 2024
| Drug name | Dosage | Payment limit | Notes |
|---|---|---|---|
| Aminocaproic acid | 250 MG | 0.319 | |
| Benzylpenicillin Benzathine (Extencilline) | 100,000 UNITS | 16.783 | |
| Diltiazem Hydrochloride | 5 MG | 0.378 | |
| Doxycycline Hyclate | 100 MG | 12.923 | |
| Famotidine | 10 MG | 0.324 | |
| Flumazenil | 0.1 MG | 1.183 | |
| Folic Acid | 5 MG | 3.17 | |
| Furosemide (Phlow Corporation) | 20 MG | 1.579 | |
| Glucarpidase | 10 UNITS | 399.73 | |
| Metoprolol Tartrate | 1 MG | 0.129 | |
| Rifampin | 600 MG | 91.656 | |
| Sodium Chloride, Hypertonic (3% - 5% infusion) | 250 CC | 1.393 | |
| Sulfamethoxazole-Trimethoprim | 400-80 MG | 0.629 |